作为疫苗制造催化剂的COVID-19:南非的一个经验
1SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Cell host & microbe
|June 15, 2023
概括
随着COVID-19疫情的爆发,疫苗分配的不平等现象被揭露出来,促使非洲疫苗制造业的投资增加. 可持续的长期战略至关重要,以保持这种势头超越短期融资.
科学领域:
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 非洲卫生系统 非洲卫生系统
背景情况:
- COVID-19暴露了全球疫苗分配中的重大差异.
- 迫切需要在非洲增强疫苗制造能力.
研究的目的:
- 分析COVID-19对非洲疫苗制造计划的影响.
- 强调非洲疫苗生产需要可持续的长期战略.
主要方法:
- 审查与非洲疫苗制造相关的科学文献和资金趋势.
- 分析政策文件和国际合作.
主要成果:
- 科研参与和国际资金的激增,为COVID-19后的非洲疫苗能力提供资金.
- 承认没有战略规划的短期投资的局限性.
结论:
- 虽然COVID-19刺激了进展,但持续的承诺和强有力的长期规划对于非洲疫苗制造业的自给自足至关重要.
- 未来的努力必须集中在建立有弹性和可持续的非洲卫生基础设施上.
相关概念视频
Vaccinations
44.8K
Overview
44.8K
Microorganisms in Medicine and Therapeutics
72
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
72


